首页|米非司酮联合宫瘤消胶囊对于子宫肌瘤患者性激素水平的影响

米非司酮联合宫瘤消胶囊对于子宫肌瘤患者性激素水平的影响

扫码查看
目的 探讨米非司酮联合宫瘤消胶囊对于子宫肌瘤患者性激素水平的影响。方法 选取 2021 年 1 月至 2023 年 1月江西百佳艾玛妇产医院的 100 例患者,随机数字表法分成两组,各 50 例。对照组采取米非司酮治疗,观察组在对照组的基础加用宫瘤消胶囊治疗。观察两组治疗效果、不良反应、月经量、子宫体积、肌瘤体积、性激素水平、血管内皮生长因子水平、月经症状及其他伴随症状积分、血液流变学。结果 干预后,观察组治疗总有效率高于对照组,差异有统计学意义(P<0。05);观察组不良反应低于对照组,差异有统计学意义(P<0。05);观察组月经量、子宫体积、肌瘤体积均小于对照组,差异有统计学意义(P<0。05);观察组和对照组孕激素、雌二醇、卵泡刺激素、黄体生成素水平低于干预前,而且观察组低于对照组,差异有统计学意义(P<0。05);观察组和对照组血管内皮生长因子水平低于干预前,而且观察组低于对照组,差异有统计学意义(P<0。05);观察组和对照组月经症状及其他伴随症状积分低于干预前,而且观察组低于对照组,差异有统计学意义(P<0。05);观察组和对照组全血还原黏度高切、全血还原黏度低切、血浆黏度值、红细胞聚集指数低于干预前,而且观察组低于对照组,差异有统计学意义(P<0。05)。结论 米非司酮联合宫瘤消胶囊治疗对于子宫肌瘤患者性激素水平有积极的影响,可以改善患者的治疗效果,不良反应较低,应用价值较高。
Effect of Mifepristone Combined with Gongliuxiao Capsules on Sex Hormone Levels in Patients with Uterine Fibroid
Objective To investigate the effect of mifepristone combined with gongliuxiao capsules on sex hormone levels in patients with uterine fibroid.Methods 100 patients admitted to Jiangxi Baijia Emma Maternity Hospital from January 2021 to January 2023 were devided into two groups by random number table method,with 50 cases in each group.The control group treated with mifepristone.On the basis of the control group,the observation group treated with gongliuxiao capsules.The therapeutic effect,adverse reactions,menstrual volume,uterine volume,lesion volume,sex hormone level,Vascular endothelial growth factor level,menstrual symptoms and other accompanying symptoms scores,and hemorheology were observed in the two groups.Results The total effective rate of the observation group was higher than that of the control group,and there was a significant difference in statistical(P<0.05);the adverse reactions in the observation group were lower than those in the control group,and there was a significant difference in statistical results(P<0.05);the menstrual volume,uterine volume,and lesion volume of the observation group were all smaller than those of the control group,with significant differences in statistical results(P<0.05);after intervention,the levels of progestin(P),estradiol(E2),follicle stimulating hormone(FSH),and luteinizing hormone(LH)in the observation group and control group were lower than before intervention,and the observation group was lower than the control group,with significant differences in statistical results(P<0.05);the level of vascular endothelial growth factor in the two groups was lower than that before intervention,and the level in the observation group was lower than that in the control group,with a statistically significant difference(P<0.05);the scores of menstrual symptoms and other accompanying symptoms in the two groups were lower than before intervention,and the observation group was lower than the control group,with statistically significant differences(P<0.05);the whole blood reduced viscosity was high shear,whole blood reduced viscosity was low shear,plasma viscosity value,and red blood cell aggregation index in the the two groups were lower than before intervention,and the observation group was lower than the control group,with statistically significant differences(P<0.05).Conclusion Mifepristone combined with gongliuxiao capsules has a positive impact on the sex hormone level of patients with Uterine fibroid,which can improve the treatment effect of patients,reduce adverse reactions of patients and have a high application value.

MifepristoneGongliuxiao capsulesUterine fibroidSex hormone

周秀琼

展开 >

江西百佳艾玛妇产医院,江西 南昌 330009

米非司酮 宫瘤消胶囊 子宫肌瘤 性激素

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(1)
  • 16